# Neurocrine’s Ingrezza flunks pivotal study in dyskinetic cerebral palsy

**Source:** Endpoints News
**URL:** https://e.endpointsnews.com/t/t-l-wojdx-jykykhhuld-d/
**Date:** 2025-12-29

---

December 23, 2025 08:28 AM EST R&D

Neu­ro­crine’s In­grez­za flunks piv­otal study in dys­k­i­net­ic cere­bral pal­sy

Ayisha Sharma

News Reporter

Neu­ro­crine Bio­sciences’ In­grez­za has failed a late-stage tri­al in a type of cere­bral pal­sy, adding to a spate of clin­i­cal dis­ap­point­ments for the biotech in …

---

#news #endpoints-news
